NIH-funded research R01 grant

Using genetics to reduce misdiagnosis of narcolepsy and sleep-wake rhythm disorders

Official title: Leveraging human genetics to overcome complex diagnostic challenges, evaluation of pan-ancestry polygenic scores to reduce misdiagnosis of narcolepsy and circadian rhythm sleep wake disorders.

Funded at Brigham and Women's Hospital · NIH-11261119 · Data updated 2026-11-12

Researchers will create genetic risk scores that work across ancestries to help people with suspected narcolepsy and circadian rhythm sleep-wake disorders get diagnosed more accurately.

More Circadian Rhythm research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBrigham and Women's Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startMarch 16, 2023
Project endJanuary 31, 2028
Funding year2026
Award (this year)$630,757
NIH project number5R01HG012810-04
Project IDNIH-11261119 on NIH RePORTER

Who could benefit from this research

Could help

People with unexplained daytime sleepiness, suspected narcolepsy, or suspected circadian rhythm sleep-wake disorders—especially those willing to share genetic data or biospecimens—are the most likely candidates to benefit.

Less likely to help

People whose sleep problems are clearly explained by other medical conditions or who are unwilling or unable to provide genetic data are unlikely to receive direct benefit from this project.

What this research studies

From a patient's point of view, this project combines large-scale genetic data to build both rare-variant and common-variant risk scores that are useful across different ancestries. The team will mine big exome and genomic repositories and expand polygenic scores to include diverse populations. The goal is to add an inexpensive, broadly available genetic tool to the current diagnostic pathway where overnight sleep testing and specialty access are often limited. If successful, these scores could be used alongside symptoms and tests to shorten the time to a correct diagnosis.

Why it matters

Potential benefit: If successful, this work could shorten delays to correct diagnosis and reduce unnecessary tests for people with suspected narcolepsy and circadian rhythm disorders.

How similar studies have gone: Genetic risk scores have helped with diagnosis or risk stratification in other conditions and some genetic markers for narcolepsy are known, but applying pan-ancestry polygenic and rare-variant scores to these rare sleep disorders is largely novel.

Where this research is happening

  • Brigham and Women's Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Gottlieb, Daniel J — Brigham and Women's Hospital
  • Study coordinator: Gottlieb, Daniel J

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.